Data as of Sep 19
| -0.10 / -0.22%|
The 4 analysts offering 12-month price forecasts for West Pharmaceutical Services Inc have a median target of 50.00, with a high estimate of 58.00 and a low estimate of 45.00. The median estimate represents a +11.63% increase from the last price of 44.79.
The current consensus among 4 polled investment analysts is to Buy stock in West Pharmaceutical Services Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.